| Jan 9, 2026 | Diagonal Therapeutics | $125.0M Series B | Janus Henderson Investors, Paulina Hill | Atlas Venture, Balyasny Asset Management, Biovision Ventures, BVF Partners, Checkpoint Capital, Deep Track Capital, EcoR1 Capital, Frazier Life Sciences, Lightspeed Venture Partners, Logos Capital, RA Capital Management, RV Invest, Velosity Capital |
| Dec 10, 2025 | Allonnia | $20.0M Series A Extension | BHP Ventures, Tom Biegala, Brett Zbar, Pivotal Capital, Viking Global Investors | — |
| Oct 16, 2025 | Veradermics | $150.0M Series C | Katarina Pance | abrdn, Infinitium, Invus, LifeSci Venture Partners, Longitude Capital, Marshall Wace, Surveyor Capital, Suvretta Capital Management |
| Sep 23, 2025 | Ensoma | $53.0M Other Equity | — | 5AM Ventures, Bill & Melinda Gates Foundation, Catalio Capital Management, Cormorant Asset Management, Delos Capital, F-Prime Capital, Gilead Sciences, Hanwha Impact, Mirae Asset, Qatar Investment Authority, RTW Investments, Solasta Ventures, SymBiosis |
| Sep 1, 2025 | Star Therapeutics | $130.0M Series D | Sanofi Ventures, Maneka Mirchandaney | Foresite Capital, OrbiMed, Sofinnova Investments, Westlake Village BioPartners, Frazier Life Sciences, Craig Gordon, Janus Henderson Investors |
| Aug 1, 2025 | SetPoint Medical | $120.0M Series D | Kevin Reilly, Josh Makower | Action Potential Venture Capital, Morgenthaler Ventures, New Enterprise Associates (NEA), Norwest Venture Partners, Runway Growth Capital, Shangbay Capital, Abbott, Ascendum Capital, Boston Scientific, Catalio Capital Management, Euclidean Capital, Gilmartin Capital, Midas Capital, Morgenthaler Ventures, New Enterprise Associates, Northwell Health, Norwest Venture Partners, Richard King Mellon Foundation, SPRIG Equity |
| Jun 3, 2025 | Antheia | $56.0M Series C | Paul Ng, CFA, Joseph Lee | ATHOS, Civilization Ventures, Federov, In-Q-Tel, S-Cubed Capital, Sherpalo Ventures |
| Apr 1, 2025 | Canopy | $70.0M Series C | Viking Global Investors | Ankona Capital, Benchmark, Deep Fork Capital, GSR Ventures, High Alpha, Hustle Fund, Kindred Ventures, Matrix, Nyca Partners, Pareto Holdings, Pelion Venture Partners, Louis Beryl, Tenaya Capital, Ten Coves Capital |
| Apr 1, 2024 | Diagonal Therapeutics | $130.0M Series A | Atlas Venture, BVF Partners | Alta Partners, Double Prime LLP, Frazier Healthcare Partners, Pareto Holdings, Passion Capital, V3 Ventures, Mik Attisani, Oscar Pierre, Tom Blomfield, Checkpoint Capital, Frazier Life Sciences, Lightspeed Venture Partners, RA Capital Management, Velosity Capital |
| Mar 1, 2024 | Sionna Therapeutics | $180.0M Series C | Edd Fleming | Atlas Venture, OrbiMed, Third Rock Ventures, Cystic Fibrosis Foundation, Perceptive Advisors, Q Healthcare Holdings, RA Capital Management, Michael Cloonan, TPG, T. Rowe Price Associates |
| Feb 1, 2024 | Areteia Therapeutics | $75.0M Series A | Bain Capital Life Sciences, Adam Koppel | ARCH Venture Partners, Biomatics Capital Partners, Citi Ventures, Polaris Partners, Vertex Ventures, Access Biotechnology, Google Ventures, Marshall Wace, Maverick Capital, Population Health Partners, Sanofi, Saturn Partners |
| Jan 1, 2024 | HI-Bio | $95.0M Bio - Series B | Chris Dimitropoulos | ARCH Venture Partners, Arkin Bio Ventures, Jeito Capital |
| Nov 1, 2023 | Keboola | $32.0M Series A | Viking Global Investors | Credo Ventures, Inovo VC, Presto Ventures, Bartosz Lipnicki, Eduard Kucera, Damir Spoljaric, Reflex Capital, TCF Capital |
| Oct 24, 2023 | DermBiont | $35.2M Series B | Daniel Yadegar | Civilization Ventures, Olive Tree Capital |
| Jul 12, 2023 | Allonnia | $30.0M Series A Extension | Tom Biegala | Battelle, BHP Ventures, Martin Reed, General Atlantic, Jason Kelly, Irongrey, PPNG, Bruno Arcadier, Wholestack |
| May 1, 2023 | Solarea Bio | $15.0M Series B | Matthew Walker | Bold Capital Partners, Social Starts, GG 1978 SICAF SIF |
| Apr 1, 2023 | ID.me | $130.0M Series D | Viking Global Investors | Alkeon Capital, GreenPoint Partners, Inspired Capital, Lux Capital, Menlo Ventures, Auctus Investment Group, CapitalG, FTV Capital, Moonshots Capital, Morgan Stanley, PSP Growth, Scout Ventures |
| Jan 26, 2023 | Pearl Health | $75.0M Debt / Series B | Scott Kupor, Viking Global Investors | Kevin Ryan, SV Angel |
| Jan 1, 2023 | Mantra Bio | $9.0M Series A | — | 8VC, ARCH Venture Partners, 8VC, Allen & Company, BoxGroup, Illumina, Samsung Securities |
| Jan 1, 2023 | Ensoma | $85.0M Series B | 5AM Ventures, Arix Bioscience | Bioluminescence Ventures, F-Prime Capital Partners, Soffinova Partners, Alexandria Venture Investments, Bill & Melinda Gates Foundation, Catalio Capital Management, Cormorant Asset Management, F-Prime Capital, Fred Hutchinson Cancer Center, Mirae Asset, Qatar Investment Authority, Solasta Ventures, SymBiosis, Takeda Ventures |
| Oct 6, 2022 | Arctic Wolf | $401.0M Other Equity | — | Neuberger Berman |
| Sep 1, 2022 | RayzeBio | $160.0M Series D | Sofinnova Investments, Viking Global Investors, Irina Margine, Ph.D. | Cambridge Innovation Capital, Forbion, Ally Bridge Group, Laurion Capital Management, Sands Capital, Soleus Capital |
| May 1, 2022 | Locus Biosciences | $35.0M Series B | — | ACME Capital, Artis Ventures (AV), Color Capital, David Namdar, Endeavor Venture Funds, M13, Jaime Schmidt, Discovery Innovations, Johnson & Johnson Innovation, Tencent |
| Feb 11, 2022 | Cazoo | $630.0M Other Equity | Viking Global Investors | D1 Capital Partners, Willoughby Capital |
| Jan 19, 2022 | Xcell Biosciences | $27.5M Series B | Shaun Rodriguez | Dynamk Capital, Formic Ventures, HBM Genomics, Labcorp |
